Sana presents corporate update at J.P. Morgan Healthcare Conference; details not in filing text

Sana Biotechnology, Inc.

Corporate presentation furnished as Exhibit 99.1 for the 42nd Annual J.P. Morgan Healthcare Conference on Jan 9, 2024.
No specific financial results, pipeline data, or guidance included in the 8-K filing text.
Company states no admission of materiality for the furnished information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.